Home/Filings/4/0001628280-19-004136
4//SEC Filing

VERTICAL GROUP LP 4

Accession 0001628280-19-004136

CIK 0001397702other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 7:04 PM ET

Size

43.7 KB

Accession

0001628280-19-004136

Insider Transaction Report

Form 4
Period: 2019-04-08
Transactions
  • Conversion

    Series A-1 Preferred Stock

    2019-04-08888,8880 total(indirect: See Footnote)
    Common Stock (888,888 underlying)
  • Conversion

    Series A-1 Preferred Stock

    2019-04-08222,2210 total(indirect: See Footnote)
    Common Stock (222,221 underlying)
  • Exercise of In-Money

    Series C Preferred Stock Warrant (Right to buy)

    2019-04-0824,6310 total(indirect: See Footnote)
    Exercise: $6.11Exp: 2023-10-13Common Stock (24,631 underlying)
  • Exercise of In-Money

    Series C Preferred Stock

    2019-04-08+49,21249,212 total(indirect: See Footnote)
    Common Stock (49,212 underlying)
  • Conversion

    Series A Preferred Stock

    2019-04-08329,6280 total(indirect: See Footnote)
    Common Stock (329,628 underlying)
  • Conversion

    Series B Preferred Stock

    2019-04-08501,5780 total(indirect: See Footnote)
    Common Stock (501,578 underlying)
  • Conversion

    Series B Preferred Stock

    2019-04-08125,3930 total(indirect: See Footnote)
    Common Stock (125,393 underlying)
  • Conversion

    Series C Preferred Stock

    2019-04-08131,2010 total(indirect: See Footnote)
    Common Stock (131,201 underlying)
  • Conversion

    Common Stock

    2019-04-08+857,655859,496 total(indirect: See Footnote)
  • Exercise of In-Money

    Series C Preferred Stock Warrant (Right to buy)

    2019-04-0898,5270 total(indirect: See Footnote)
    Exercise: $6.11Exp: 2023-10-13Common Stock (98,527 underlying)
  • Exercise of In-Money

    Series C Preferred Stock

    2019-04-08+196,855196,855 total(indirect: See Footnote)
    Common Stock (196,855 underlying)
  • Conversion

    Series C Preferred Stock

    2019-04-08524,8140 total(indirect: See Footnote)
    Common Stock (524,814 underlying)
  • Exercise of In-Money

    Series C Preferred Stock Warrant (Right to buy)

    2019-04-0824,5810 total(indirect: See Footnote)
    Exercise: $6.11Exp: 2022-08-07Common Stock (24,581 underlying)
  • Conversion

    Common Stock

    2019-04-08+3,412,1333,419,453 total(indirect: See Footnote)
  • Conversion

    Series A Preferred Stock

    2019-04-081,299,9980 total(indirect: See Footnote)
    Common Stock (1,299,998 underlying)
  • Exercise of In-Money

    Series C Preferred Stock Warrant (Right to buy)

    2019-04-0898,3280 total(indirect: See Footnote)
    Exercise: $6.11Exp: 2022-08-07Common Stock (98,328 underlying)
  • Conversion

    Series C Preferred Stock

    2019-04-08246,0670 total(indirect: See Footnote)
    Common Stock (246,067 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    741
Footnotes (15)
  • [F1]The Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  • [F10]This warrant is held by VFI.
  • [F11]VFII paid cash to exercise this warrant to purchase shares of the Issuer's Series C Preferred Stock.
  • [F12]This warrant is held by VFII.
  • [F13]These shares are held by VFI.
  • [F14]These shares are held by VFII.
  • [F15]Prior to conversion to Common Stock, these shares are comprised of 196,855 shares held by VFI and 49,212 shares held by VFII.
  • [F2]The total of 3,419,453 shares beneficially owned is comprised of (i) 7,320 shares of Common Stock held prior to the date hereof (ii) a total of 3,215,278 shares of Common Stock issued upon conversion of Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series C Preferred Stock held prior to the date hereof, and (iii) a total of 196,855 shares of Common Stock issued upon conversion of Series C Preferred Stock issued pursuant to the exercise of warrants, as detailed in footnote (8)
  • [F3]These shares are held directly by Vertical Fund I, L.P. ("VFI").
  • [F4]The Vertical Group, L.P., a Delaware limited partnership, is the sole general partner of each of VFI and Vertical Fund II, L.P. ("VFII"), and The Vertical Group GP, LLC, a Delaware limited liability company, controls The Vertical Group, L.P. The sole members and managers of The Vertical Group GP, LLC are Messrs. Tony M. Chou, Richard B. Emmitt, Jack W. Lasersohn and John E. Runnells. These four individuals share voting and investment power over securities held by The Vertical Group, Inc. ("VGI"), VFI and VFII, and each disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
  • [F5]The total of 859,496 shares beneficially owned is comprised of (i) 1,841 shares of Common Stock held prior to the date hereof (ii) a total of 808,443 shares of Common Stock issued upon conversion of Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series C Preferred Stock held prior to the date hereof, and (iii) a total of 49,212 shares of Common Stock issued upon conversion of Series C Preferred Stock issued pursuant to the exercise of warrants, as detailed in footnote (11).
  • [F6]These shares are held directly by VFII.
  • [F7]These shares are held directly by VGI.
  • [F8]VFI paid cash to exercise this warrant to purchase shares of the Issuer's Series C Preferred Stock.
  • [F9]All of the shares subject to the warrant are fully exercisable as of the date hereof.

Issuer

Silk Road Medical Inc

CIK 0001397702

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001180179

Filing Metadata

Form type
4
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 7:04 PM ET
Size
43.7 KB